Company Filing History:
Years Active: 2003
Title: Jörg Ogorka: Innovator in Pharmaceutical Compositions
Introduction
Jörg Ogorka is a notable inventor based in Steinen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release oral compositions.
Latest Patents
Jörg Ogorka holds a patent for "Controlled release oral compositions comprising rivastigmine." This pharmaceutical composition is capable of releasing a therapeutically effective dose of the active agent, rivastigmine, in a time-controlled manner. His innovative approach enhances the efficacy of treatment for patients requiring this medication.
Career Highlights
Ogorka is associated with Novartis AG, a leading global healthcare company. His work focuses on advancing pharmaceutical technologies that improve patient outcomes. With a strong commitment to research and development, he has established himself as a key player in the industry.
Collaborations
Some of his notable coworkers include Oskar Michael Kalb and Rajen Dhirubhai Shah. Their collaborative efforts contribute to the success of various projects within the pharmaceutical sector.
Conclusion
Jörg Ogorka's contributions to pharmaceutical innovations, particularly in controlled release formulations, highlight his expertise and dedication to improving healthcare solutions. His work continues to impact the industry positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.